Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-07-15

AUTHORS

Cris A. Slentz, Lori A. Bateman, Leslie H. Willis, Esther O. Granville, Lucy W. Piner, Gregory P. Samsa, Tracy L. Setji, Michael J. Muehlbauer, Kim M. Huffman, Connie W. Bales, William E. Kraus

ABSTRACT

Aims/hypothesisAlthough the Diabetes Prevention Program (DPP) established lifestyle changes (diet, exercise and weight loss) as the ‘gold standard’ preventive therapy for diabetes, the relative contribution of exercise alone to the overall utility of the combined diet and exercise effect of DPP is unknown; furthermore, the optimal intensity of exercise for preventing progression to diabetes remains very controversial. To establish clinical efficacy, we undertook a study (2009 to 2013) to determine: how much of the effect on measures of glucose homeostasis of a 6 month programme modelled after the first 6 months of the DPP is due to exercise alone; whether moderate- or vigorous-intensity exercise is better for improving glucose homeostasis; and to what extent amount of exercise is a contributor to improving glucose control. The primary outcome was improvement in fasting plasma glucose, with improvement in plasma glucose AUC response to an OGTT as the major secondary outcome.MethodsThe trial was a parallel clinical trial. Sedentary, non-smokers who were 45–75 year old adults (n = 237) with elevated fasting glucose (5.28–6.94 mmol/l) but without cardiovascular disease, uncontrolled hypertension, or diabetes, from the Durham area, were studied at Duke University. They were randomised into one of four 6 month interventions: (1) low amount (42 kJ kg body weight−1 week−1 [KKW])/moderate intensity: equivalent of expending 42 KKW (e.g. walking ∼16 km [8.6 miles] per week) with moderate-intensity (50% V.O2reserve\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \overset{.}{V}{\mathrm{O}}_{2\mathrm{reserve}} $$\end{document}) exercise; (2) high amount (67 KKW)/moderate intensity: equivalent of expending 67 KKW (∼22.3 km [13.8 miles] per week) with moderate-intensity exercise; (3) high amount (67 KKW)/vigorous intensity: equivalent to group 2, but with vigorous-intensity exercise (75% V.O2reserve\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \overset{.}{V}{\mathrm{O}}_{2\mathrm{reserve}} $$\end{document}); and (4) diet + 42 KKW moderate intensity: same as group 1 but with diet and weight loss (7%) to mimic the first 6 months of the DPP. Computer-generated randomisation lists were provided by our statistician (G. P. Samsa). The randomisation list was maintained by L. H. Willis and C. A. Slentz with no knowledge of or input into the scheduling, whereas all scheduling was done by L. A. Bateman, with no knowledge of the randomisation list. Subjects were automatically assigned to the next group listed on the randomisation sheet (with no ability to manipulate the list order) on the day that they came in for the OGTT, by L. H. Willis. All plasma analysis was done blinded by the individuals doing the measurements (i.e. lipids, glucose, insulin). Subjects and research staff (other than individuals analysing the blood) were not blinded to the group assignments.ResultsNumber randomised, completers and number analysed with complete OGTT data for each group were: low-amount/moderate-intensity (61, 43, 35); high-amount/moderate-intensity (61, 44, 40); high-amount/vigorous-intensity (61, 43, 38); diet/exercise (54, 45, 37), respectively. Only the diet and exercise group experienced a decrease in fasting glucose (p < 0.001). The means and 95% CIs for changes in fasting glucose (mmol/l) for each group were: high-amount/moderate-intensity −0.07 (−0.20, 0.06); high-amount/vigorous 0.06 (−0.07, 0.19); low-amount/moderate 0.05 (−0.05, 0.15); and diet/exercise −0.32 (−0.46, −0.18). The effects sizes for each group (in the same order) were: 0.17, 0.15, 0.18 and 0.71, respecively. For glucose tolerance (glucose AUC of OGTT), similar improvements were observed for the diet and exercise (8.2% improvement, effect size 0.73) and the 67 KKW moderate-intensity exercise (6.4% improvement, effect size 0.60) groups; moderate-intensity exercise was significantly more effective than the same amount of vigorous-intensity exercise (p < 0.0207). The equivalent amount of vigorous-intensity exercise alone did not significantly improve glucose tolerance (1.2% improvement, effect size 0.21). Changes in insulin AUC, fasting plasma glucose and insulin did not differ among the exercise groups and were numerically inferior to the diet and exercise group.Conclusions/interpretationIn the present clinical efficacy trial we found that a high amount of moderate-intensity exercise alone was very effective at improving oral glucose tolerance despite a relatively modest 2 kg change in body fat mass. These data, combined with numerous published observations of the strong independent relation between postprandial glucose concentrations and prediction of future diabetes, suggest that walking ∼18.2 km (22.3 km prescribed with 81.6% adherence in the 67 KKW moderate-intensity group) per week may be nearly as effective as a more intensive multicomponent approach involving diet, exercise and weight loss for preventing the progression to diabetes in prediabetic individuals. These findings have important implications for the choice of clinical intervention to prevent progression to type 2 diabetes for those at high risk.Trial registration:ClinicalTrials.gov NCT00962962Funding:The study was funded by National Institutes for Health National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NDDK) (R01DK081559) More... »

PAGES

2088-2098

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00125-016-4051-z

DOI

http://dx.doi.org/10.1007/s00125-016-4051-z

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1026946623

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27421729


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Blood Glucose", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Exercise", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Glucose Tolerance Test", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Homeostasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Life Style", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prediabetic State", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Weight Loss", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Slentz", 
        "givenName": "Cris A.", 
        "id": "sg:person.01342460612.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342460612.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of North Carolina at Chapel Hill, Center for Health Promotion and Disease Prevention, Chapel Hill, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.10698.36", 
          "name": [
            "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA", 
            "University of North Carolina at Chapel Hill, Center for Health Promotion and Disease Prevention, Chapel Hill, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bateman", 
        "givenName": "Lori A.", 
        "id": "sg:person.01354170443.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354170443.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Willis", 
        "givenName": "Leslie H.", 
        "id": "sg:person.0727212312.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727212312.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Geriatrics, Duke University School of Medicine, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Division of Geriatrics, Duke University School of Medicine, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Granville", 
        "givenName": "Esther O.", 
        "id": "sg:person.0755300141.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755300141.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Piner", 
        "givenName": "Lucy W.", 
        "id": "sg:person.0724731546.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724731546.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Samsa", 
        "givenName": "Gregory P.", 
        "id": "sg:person.016672356017.04", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016672356017.04"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Endocrinology, Duke University School of Medicine, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Division of Endocrinology, Duke University School of Medicine, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Setji", 
        "givenName": "Tracy L.", 
        "id": "sg:person.0641063674.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641063674.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Muehlbauer", 
        "givenName": "Michael J.", 
        "id": "sg:person.012662070407.87", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012662070407.87"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Huffman", 
        "givenName": "Kim M.", 
        "id": "sg:person.01133572043.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133572043.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Geriatrics, Duke University School of Medicine, Durham, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Division of Geriatrics, Duke University School of Medicine, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bales", 
        "givenName": "Connie W.", 
        "id": "sg:person.01025071211.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025071211.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiology, Duke University School of Medicine, Durham,, NC, USA", 
          "id": "http://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA", 
            "Division of Cardiology, Duke University School of Medicine, Durham,, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kraus", 
        "givenName": "William E.", 
        "id": "sg:person.01226002512.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226002512.56"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s001250051249", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027638373", 
          "https://doi.org/10.1007/s001250051249"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-07-15", 
    "datePublishedReg": "2016-07-15", 
    "description": "Aims/hypothesisAlthough the Diabetes Prevention Program (DPP) established lifestyle changes (diet, exercise and weight loss) as the \u2018gold standard\u2019 preventive therapy for diabetes, the relative contribution of exercise alone to the overall utility of the combined diet and exercise effect of DPP is unknown; furthermore, the optimal intensity of exercise for preventing progression to diabetes remains very controversial. To establish clinical efficacy, we undertook a study (2009 to 2013) to determine: how much of the effect on measures of glucose homeostasis of a 6\u00a0month programme modelled after the first 6\u00a0months of the DPP is due to exercise alone; whether moderate- or vigorous-intensity exercise is better for improving glucose homeostasis; and to what extent amount of exercise is a contributor to improving glucose control. The primary outcome was improvement in fasting plasma glucose, with improvement in plasma glucose AUC response to an OGTT as the major secondary outcome.MethodsThe trial was a parallel clinical trial. Sedentary, non-smokers who were 45\u201375\u00a0year old adults (n\u2009=\u2009237) with elevated fasting glucose (5.28\u20136.94\u00a0mmol/l) but without cardiovascular disease, uncontrolled hypertension, or diabetes, from the Durham area, were studied at Duke University. They were randomised into one of four 6\u00a0month interventions: (1) low amount (42\u00a0kJ\u00a0kg body weight\u22121 week\u22121 [KKW])/moderate intensity: equivalent of expending 42 KKW (e.g. walking \u223c16\u00a0km [8.6 miles] per week) with moderate-intensity (50% V.O2reserve\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym}\n\t\t\t\t\\usepackage{amsfonts}\n\t\t\t\t\\usepackage{amssymb}\n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overset{.}{V}{\\mathrm{O}}_{2\\mathrm{reserve}} $$\\end{document}) exercise; (2) high amount (67 KKW)/moderate intensity: equivalent of expending 67 KKW (\u223c22.3\u00a0km [13.8 miles] per week) with moderate-intensity exercise; (3) high amount (67 KKW)/vigorous intensity: equivalent to group 2, but with vigorous-intensity exercise (75% V.O2reserve\\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym}\n\t\t\t\t\\usepackage{amsfonts}\n\t\t\t\t\\usepackage{amssymb}\n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$ \\overset{.}{V}{\\mathrm{O}}_{2\\mathrm{reserve}} $$\\end{document}); and (4) diet\u2009+\u200942 KKW moderate intensity: same as group 1 but with diet and weight loss (7%) to mimic the first 6\u00a0months of the DPP. Computer-generated randomisation lists were provided by our statistician (G. P. Samsa). The randomisation list was maintained by L. H. Willis and C. A. Slentz with no knowledge of or input into the scheduling, whereas all scheduling was done by L. A. Bateman, with no knowledge of the randomisation list. Subjects were automatically assigned to the next group listed on the randomisation sheet (with no ability to manipulate the list order) on the day that they came in for the OGTT, by L. H. Willis. All plasma analysis was done blinded by the individuals doing the measurements (i.e. lipids, glucose, insulin). Subjects and research staff (other than individuals analysing the blood) were not blinded to the group assignments.ResultsNumber randomised, completers and number analysed with complete OGTT data for each group were: low-amount/moderate-intensity (61, 43, 35); high-amount/moderate-intensity (61, 44, 40); high-amount/vigorous-intensity (61, 43, 38); diet/exercise (54, 45, 37), respectively. Only the diet and exercise group experienced a decrease in fasting glucose (p\u2009<\u20090.001). The means and 95% CIs for changes in fasting glucose (mmol/l) for each group were: high-amount/moderate-intensity \u22120.07 (\u22120.20, 0.06); high-amount/vigorous 0.06 (\u22120.07, 0.19); low-amount/moderate 0.05 (\u22120.05, 0.15); and diet/exercise \u22120.32 (\u22120.46, \u22120.18). The effects sizes for each group (in the same order) were: 0.17, 0.15, 0.18 and 0.71, respecively. For glucose tolerance (glucose AUC of OGTT), similar improvements were observed for the diet and exercise (8.2% improvement, effect size 0.73) and the 67 KKW moderate-intensity exercise (6.4% improvement, effect size 0.60) groups; moderate-intensity exercise was significantly more effective than the same amount of vigorous-intensity exercise (p\u2009<\u20090.0207). The equivalent amount of vigorous-intensity exercise alone did not significantly improve glucose tolerance (1.2% improvement, effect size 0.21). Changes in insulin AUC, fasting plasma glucose and insulin did not differ among the exercise groups and were numerically inferior to the diet and exercise group.Conclusions/interpretationIn the present clinical efficacy trial we found that a high amount of moderate-intensity exercise alone was very effective at improving oral glucose tolerance despite a relatively modest 2\u00a0kg change in body fat mass. These data, combined with numerous published observations of the strong independent relation between postprandial glucose concentrations and prediction of future diabetes, suggest that walking \u223c18.2\u00a0km (22.3\u00a0km prescribed with 81.6% adherence in the 67 KKW moderate-intensity group) per week may be nearly as effective as a more intensive multicomponent approach involving diet, exercise and weight loss for preventing the progression to diabetes in prediabetic individuals. These findings have important implications for the choice of clinical intervention to prevent progression to type 2 diabetes for those at high risk.Trial registration:ClinicalTrials.gov NCT00962962Funding:The study was funded by National Institutes for Health National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NDDK) (R01DK081559)", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00125-016-4051-z", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2499670", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1001482", 
        "issn": [
          "0012-186X", 
          "1432-0428"
        ], 
        "name": "Diabetologia", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "59"
      }
    ], 
    "keywords": [
      "Diabetes Prevention Program", 
      "vigorous-intensity exercise", 
      "moderate-intensity exercise", 
      "diet/exercise", 
      "randomisation list", 
      "exercise group", 
      "glucose tolerance", 
      "glucose homeostasis", 
      "prediabetic individuals", 
      "plasma glucose", 
      "computer-generated randomisation list", 
      "weight loss", 
      "major secondary outcomes", 
      "parallel clinical trial", 
      "oral glucose tolerance", 
      "clinical efficacy trials", 
      "postprandial glucose concentrations", 
      "Conclusions/interpretationIn", 
      "body fat mass", 
      "type 2 diabetes", 
      "National Institute", 
      "Health-National Institute", 
      "year old adults", 
      "strong independent relation", 
      "uncontrolled hypertension", 
      "future diabetes", 
      "preventive therapy", 
      "Secondary outcomes", 
      "insulin AUC", 
      "lifestyle intervention", 
      "primary outcome", 
      "exercise training", 
      "clinical efficacy", 
      "glucose control", 
      "months intervention", 
      "combined exercise", 
      "AUC response", 
      "clinical trials", 
      "OGTT data", 
      "fat mass", 
      "cardiovascular disease", 
      "exercise effects", 
      "efficacy trials", 
      "MethodsThe trial", 
      "lifestyle changes", 
      "high risk", 
      "group 2", 
      "Aims/", 
      "group 1", 
      "diabetes", 
      "prevention programs", 
      "clinical interventions", 
      "older adults", 
      "month program", 
      "trials", 
      "gold standard", 
      "group assignment", 
      "moderate intensity", 
      "diet", 
      "progression", 
      "OGTT", 
      "glucose concentration", 
      "similar improvements", 
      "disease effects", 
      "exercise", 
      "intervention", 
      "research staff", 
      "independent relation", 
      "glucose", 
      "homeostasis", 
      "months", 
      "optimal intensity", 
      "outcomes", 
      "group", 
      "KKW", 
      "Willis", 
      "subjects", 
      "high amounts", 
      "individuals", 
      "hypertension", 
      "interpretationIn", 
      "therapy", 
      "Duke University", 
      "ResultsNumber", 
      "Digestive", 
      "Durham area", 
      "insulin", 
      "disease", 
      "completers", 
      "weeks", 
      "AUC", 
      "efficacy", 
      "equivalent amount", 
      "next group", 
      "adults", 
      "effect", 
      "risk", 
      "changes", 
      "tolerance", 
      "study", 
      "improvement", 
      "Institute", 
      "relative contribution", 
      "plasma analysis", 
      "days", 
      "important implications", 
      "loss", 
      "same amount", 
      "low amounts", 
      "multicomponent approach", 
      "staff", 
      "findings", 
      "list", 
      "program", 
      "response", 
      "data", 
      "decrease", 
      "control", 
      "overall utility", 
      "knowledge", 
      "measures", 
      "training", 
      "equivalent", 
      "utility", 
      "contributor", 
      "intensity", 
      "amount", 
      "concentration", 
      "cis", 
      "mass", 
      "number", 
      "standards", 
      "choice", 
      "analysis", 
      "implications", 
      "area", 
      "University", 
      "means", 
      "observations", 
      "relation", 
      "measurements", 
      "statisticians", 
      "approach", 
      "extent amount", 
      "contribution", 
      "input", 
      "prediction", 
      "Bateman", 
      "assignment", 
      "sheets", 
      "scheduling"
    ], 
    "name": "Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial", 
    "pagination": "2088-2098", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1026946623"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00125-016-4051-z"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27421729"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00125-016-4051-z", 
      "https://app.dimensions.ai/details/publication/pub.1026946623"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T15:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_695.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00125-016-4051-z"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00125-016-4051-z'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00125-016-4051-z'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00125-016-4051-z'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00125-016-4051-z'


 

This table displays all metadata directly associated to this object as RDF triples.

356 TRIPLES      21 PREDICATES      191 URIs      182 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00125-016-4051-z schema:about N1b1eaccbe59a4baca27fb7e8cbff0625
2 N1d77a3e5c37141ecb3932fc60ac72635
3 N1f95d5bda42f4dc0bc12532f4c0751fc
4 N259eafd458c742df9ac1c54de718c9da
5 N29d7bdad0b7a42eba35dda98c94e9590
6 N58344f8ea44644e29363a2c8697a4944
7 N687881a306ed488b8aac37d6fa45d586
8 N7867f24291834baa9565dc699fef135e
9 N7b98aa6ab5424b009e4eab46e77f9125
10 Naca9194768d04099bd4f93a8fac17e6f
11 Nb189ba1cc5954c3ca9ed2b556bf77d4e
12 Nbd415e6480b6454ea2b0d6df07bc0f50
13 Nbd78f08dbee0419889daa652c419cd7c
14 Nf613578499864ab6921e84b5808c65ea
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N009abe83ad144501a7de84ecc99e7801
18 schema:citation sg:pub.10.1007/s001250051249
19 schema:datePublished 2016-07-15
20 schema:datePublishedReg 2016-07-15
21 schema:description Aims/hypothesisAlthough the Diabetes Prevention Program (DPP) established lifestyle changes (diet, exercise and weight loss) as the ‘gold standard’ preventive therapy for diabetes, the relative contribution of exercise alone to the overall utility of the combined diet and exercise effect of DPP is unknown; furthermore, the optimal intensity of exercise for preventing progression to diabetes remains very controversial. To establish clinical efficacy, we undertook a study (2009 to 2013) to determine: how much of the effect on measures of glucose homeostasis of a 6 month programme modelled after the first 6 months of the DPP is due to exercise alone; whether moderate- or vigorous-intensity exercise is better for improving glucose homeostasis; and to what extent amount of exercise is a contributor to improving glucose control. The primary outcome was improvement in fasting plasma glucose, with improvement in plasma glucose AUC response to an OGTT as the major secondary outcome.MethodsThe trial was a parallel clinical trial. Sedentary, non-smokers who were 45–75 year old adults (n = 237) with elevated fasting glucose (5.28–6.94 mmol/l) but without cardiovascular disease, uncontrolled hypertension, or diabetes, from the Durham area, were studied at Duke University. They were randomised into one of four 6 month interventions: (1) low amount (42 kJ kg body weight−1 week−1 [KKW])/moderate intensity: equivalent of expending 42 KKW (e.g. walking ∼16 km [8.6 miles] per week) with moderate-intensity (50% V.O2reserve\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \overset{.}{V}{\mathrm{O}}_{2\mathrm{reserve}} $$\end{document}) exercise; (2) high amount (67 KKW)/moderate intensity: equivalent of expending 67 KKW (∼22.3 km [13.8 miles] per week) with moderate-intensity exercise; (3) high amount (67 KKW)/vigorous intensity: equivalent to group 2, but with vigorous-intensity exercise (75% V.O2reserve\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \overset{.}{V}{\mathrm{O}}_{2\mathrm{reserve}} $$\end{document}); and (4) diet + 42 KKW moderate intensity: same as group 1 but with diet and weight loss (7%) to mimic the first 6 months of the DPP. Computer-generated randomisation lists were provided by our statistician (G. P. Samsa). The randomisation list was maintained by L. H. Willis and C. A. Slentz with no knowledge of or input into the scheduling, whereas all scheduling was done by L. A. Bateman, with no knowledge of the randomisation list. Subjects were automatically assigned to the next group listed on the randomisation sheet (with no ability to manipulate the list order) on the day that they came in for the OGTT, by L. H. Willis. All plasma analysis was done blinded by the individuals doing the measurements (i.e. lipids, glucose, insulin). Subjects and research staff (other than individuals analysing the blood) were not blinded to the group assignments.ResultsNumber randomised, completers and number analysed with complete OGTT data for each group were: low-amount/moderate-intensity (61, 43, 35); high-amount/moderate-intensity (61, 44, 40); high-amount/vigorous-intensity (61, 43, 38); diet/exercise (54, 45, 37), respectively. Only the diet and exercise group experienced a decrease in fasting glucose (p < 0.001). The means and 95% CIs for changes in fasting glucose (mmol/l) for each group were: high-amount/moderate-intensity −0.07 (−0.20, 0.06); high-amount/vigorous 0.06 (−0.07, 0.19); low-amount/moderate 0.05 (−0.05, 0.15); and diet/exercise −0.32 (−0.46, −0.18). The effects sizes for each group (in the same order) were: 0.17, 0.15, 0.18 and 0.71, respecively. For glucose tolerance (glucose AUC of OGTT), similar improvements were observed for the diet and exercise (8.2% improvement, effect size 0.73) and the 67 KKW moderate-intensity exercise (6.4% improvement, effect size 0.60) groups; moderate-intensity exercise was significantly more effective than the same amount of vigorous-intensity exercise (p < 0.0207). The equivalent amount of vigorous-intensity exercise alone did not significantly improve glucose tolerance (1.2% improvement, effect size 0.21). Changes in insulin AUC, fasting plasma glucose and insulin did not differ among the exercise groups and were numerically inferior to the diet and exercise group.Conclusions/interpretationIn the present clinical efficacy trial we found that a high amount of moderate-intensity exercise alone was very effective at improving oral glucose tolerance despite a relatively modest 2 kg change in body fat mass. These data, combined with numerous published observations of the strong independent relation between postprandial glucose concentrations and prediction of future diabetes, suggest that walking ∼18.2 km (22.3 km prescribed with 81.6% adherence in the 67 KKW moderate-intensity group) per week may be nearly as effective as a more intensive multicomponent approach involving diet, exercise and weight loss for preventing the progression to diabetes in prediabetic individuals. These findings have important implications for the choice of clinical intervention to prevent progression to type 2 diabetes for those at high risk.Trial registration:ClinicalTrials.gov NCT00962962Funding:The study was funded by National Institutes for Health National Institute of Diabetes and Digestive and Kidney Diseases (NIH-NDDK) (R01DK081559)
22 schema:genre article
23 schema:isAccessibleForFree true
24 schema:isPartOf N547ae012a06c42818410250601e3426e
25 Nc4a861dbd7e1477c971e1938798a0e3d
26 sg:journal.1001482
27 schema:keywords AUC
28 AUC response
29 Aims/
30 Bateman
31 Conclusions/interpretationIn
32 Diabetes Prevention Program
33 Digestive
34 Duke University
35 Durham area
36 Health-National Institute
37 Institute
38 KKW
39 MethodsThe trial
40 National Institute
41 OGTT
42 OGTT data
43 ResultsNumber
44 Secondary outcomes
45 University
46 Willis
47 adults
48 amount
49 analysis
50 approach
51 area
52 assignment
53 body fat mass
54 cardiovascular disease
55 changes
56 choice
57 cis
58 clinical efficacy
59 clinical efficacy trials
60 clinical interventions
61 clinical trials
62 combined exercise
63 completers
64 computer-generated randomisation list
65 concentration
66 contribution
67 contributor
68 control
69 data
70 days
71 decrease
72 diabetes
73 diet
74 diet/exercise
75 disease
76 disease effects
77 effect
78 efficacy
79 efficacy trials
80 equivalent
81 equivalent amount
82 exercise
83 exercise effects
84 exercise group
85 exercise training
86 extent amount
87 fat mass
88 findings
89 future diabetes
90 glucose
91 glucose concentration
92 glucose control
93 glucose homeostasis
94 glucose tolerance
95 gold standard
96 group
97 group 1
98 group 2
99 group assignment
100 high amounts
101 high risk
102 homeostasis
103 hypertension
104 implications
105 important implications
106 improvement
107 independent relation
108 individuals
109 input
110 insulin
111 insulin AUC
112 intensity
113 interpretationIn
114 intervention
115 knowledge
116 lifestyle changes
117 lifestyle intervention
118 list
119 loss
120 low amounts
121 major secondary outcomes
122 mass
123 means
124 measurements
125 measures
126 moderate intensity
127 moderate-intensity exercise
128 month program
129 months
130 months intervention
131 multicomponent approach
132 next group
133 number
134 observations
135 older adults
136 optimal intensity
137 oral glucose tolerance
138 outcomes
139 overall utility
140 parallel clinical trial
141 plasma analysis
142 plasma glucose
143 postprandial glucose concentrations
144 prediabetic individuals
145 prediction
146 prevention programs
147 preventive therapy
148 primary outcome
149 program
150 progression
151 randomisation list
152 relation
153 relative contribution
154 research staff
155 response
156 risk
157 same amount
158 scheduling
159 sheets
160 similar improvements
161 staff
162 standards
163 statisticians
164 strong independent relation
165 study
166 subjects
167 therapy
168 tolerance
169 training
170 trials
171 type 2 diabetes
172 uncontrolled hypertension
173 utility
174 vigorous-intensity exercise
175 weeks
176 weight loss
177 year old adults
178 schema:name Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial
179 schema:pagination 2088-2098
180 schema:productId N0eed9a2d7872493982629041c0f1c059
181 N5116c87aa11a4bb09c83f7ee8b3a2dbd
182 Ndf1bb62e75ad4dcb8ac70f88d4f604d5
183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026946623
184 https://doi.org/10.1007/s00125-016-4051-z
185 schema:sdDatePublished 2022-09-02T15:59
186 schema:sdLicense https://scigraph.springernature.com/explorer/license/
187 schema:sdPublisher N9c957bf31468495e94dd5462452b9af0
188 schema:url https://doi.org/10.1007/s00125-016-4051-z
189 sgo:license sg:explorer/license/
190 sgo:sdDataset articles
191 rdf:type schema:ScholarlyArticle
192 N009abe83ad144501a7de84ecc99e7801 rdf:first sg:person.01342460612.05
193 rdf:rest Nb943de6a20c740ac94480f714a747c74
194 N034109485163439fbfe9eeaf1a5bdaa7 rdf:first sg:person.0727212312.25
195 rdf:rest N20c385f86daa45498539b328f60c86c7
196 N0a9bb655b24f469fa263b7c96006bd0b rdf:first sg:person.01025071211.38
197 rdf:rest N664a5af8ffd64bd3abedf53eba4550ac
198 N0eb44d07f65f4e3bb79a7e4af20a29d6 rdf:first sg:person.012662070407.87
199 rdf:rest Nb02c4c9551004bbcb385a8cf84285f54
200 N0eed9a2d7872493982629041c0f1c059 schema:name dimensions_id
201 schema:value pub.1026946623
202 rdf:type schema:PropertyValue
203 N19422cfc1bf746fe8066cbddfdc33123 rdf:first sg:person.016672356017.04
204 rdf:rest Ncd22a9e8cd464d7daff4248d36e0ed13
205 N1b1eaccbe59a4baca27fb7e8cbff0625 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
206 schema:name Life Style
207 rdf:type schema:DefinedTerm
208 N1d77a3e5c37141ecb3932fc60ac72635 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
209 schema:name Aged
210 rdf:type schema:DefinedTerm
211 N1f95d5bda42f4dc0bc12532f4c0751fc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
212 schema:name Weight Loss
213 rdf:type schema:DefinedTerm
214 N20c385f86daa45498539b328f60c86c7 rdf:first sg:person.0755300141.18
215 rdf:rest Ncb535492af084e2faaa94e5f7a3a753f
216 N259eafd458c742df9ac1c54de718c9da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
217 schema:name Exercise
218 rdf:type schema:DefinedTerm
219 N29d7bdad0b7a42eba35dda98c94e9590 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
220 schema:name Humans
221 rdf:type schema:DefinedTerm
222 N5116c87aa11a4bb09c83f7ee8b3a2dbd schema:name doi
223 schema:value 10.1007/s00125-016-4051-z
224 rdf:type schema:PropertyValue
225 N547ae012a06c42818410250601e3426e schema:volumeNumber 59
226 rdf:type schema:PublicationVolume
227 N58344f8ea44644e29363a2c8697a4944 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
228 schema:name Diabetes Mellitus, Type 2
229 rdf:type schema:DefinedTerm
230 N664a5af8ffd64bd3abedf53eba4550ac rdf:first sg:person.01226002512.56
231 rdf:rest rdf:nil
232 N687881a306ed488b8aac37d6fa45d586 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
233 schema:name Male
234 rdf:type schema:DefinedTerm
235 N7867f24291834baa9565dc699fef135e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
236 schema:name Prediabetic State
237 rdf:type schema:DefinedTerm
238 N7b98aa6ab5424b009e4eab46e77f9125 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
239 schema:name Female
240 rdf:type schema:DefinedTerm
241 N9c957bf31468495e94dd5462452b9af0 schema:name Springer Nature - SN SciGraph project
242 rdf:type schema:Organization
243 Naca9194768d04099bd4f93a8fac17e6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
244 schema:name Homeostasis
245 rdf:type schema:DefinedTerm
246 Nb02c4c9551004bbcb385a8cf84285f54 rdf:first sg:person.01133572043.98
247 rdf:rest N0a9bb655b24f469fa263b7c96006bd0b
248 Nb189ba1cc5954c3ca9ed2b556bf77d4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
249 schema:name Glucose Tolerance Test
250 rdf:type schema:DefinedTerm
251 Nb943de6a20c740ac94480f714a747c74 rdf:first sg:person.01354170443.83
252 rdf:rest N034109485163439fbfe9eeaf1a5bdaa7
253 Nbd415e6480b6454ea2b0d6df07bc0f50 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
254 schema:name Blood Glucose
255 rdf:type schema:DefinedTerm
256 Nbd78f08dbee0419889daa652c419cd7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
257 schema:name Middle Aged
258 rdf:type schema:DefinedTerm
259 Nc4a861dbd7e1477c971e1938798a0e3d schema:issueNumber 10
260 rdf:type schema:PublicationIssue
261 Ncb535492af084e2faaa94e5f7a3a753f rdf:first sg:person.0724731546.00
262 rdf:rest N19422cfc1bf746fe8066cbddfdc33123
263 Ncd22a9e8cd464d7daff4248d36e0ed13 rdf:first sg:person.0641063674.88
264 rdf:rest N0eb44d07f65f4e3bb79a7e4af20a29d6
265 Ndf1bb62e75ad4dcb8ac70f88d4f604d5 schema:name pubmed_id
266 schema:value 27421729
267 rdf:type schema:PropertyValue
268 Nf613578499864ab6921e84b5808c65ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
269 schema:name Insulin
270 rdf:type schema:DefinedTerm
271 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
272 schema:name Medical and Health Sciences
273 rdf:type schema:DefinedTerm
274 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
275 schema:name Clinical Sciences
276 rdf:type schema:DefinedTerm
277 sg:grant.2499670 http://pending.schema.org/fundedItem sg:pub.10.1007/s00125-016-4051-z
278 rdf:type schema:MonetaryGrant
279 sg:journal.1001482 schema:issn 0012-186X
280 1432-0428
281 schema:name Diabetologia
282 schema:publisher Springer Nature
283 rdf:type schema:Periodical
284 sg:person.01025071211.38 schema:affiliation grid-institutes:grid.26009.3d
285 schema:familyName Bales
286 schema:givenName Connie W.
287 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025071211.38
288 rdf:type schema:Person
289 sg:person.01133572043.98 schema:affiliation grid-institutes:grid.26009.3d
290 schema:familyName Huffman
291 schema:givenName Kim M.
292 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01133572043.98
293 rdf:type schema:Person
294 sg:person.01226002512.56 schema:affiliation grid-institutes:grid.26009.3d
295 schema:familyName Kraus
296 schema:givenName William E.
297 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226002512.56
298 rdf:type schema:Person
299 sg:person.012662070407.87 schema:affiliation grid-institutes:grid.26009.3d
300 schema:familyName Muehlbauer
301 schema:givenName Michael J.
302 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012662070407.87
303 rdf:type schema:Person
304 sg:person.01342460612.05 schema:affiliation grid-institutes:grid.26009.3d
305 schema:familyName Slentz
306 schema:givenName Cris A.
307 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342460612.05
308 rdf:type schema:Person
309 sg:person.01354170443.83 schema:affiliation grid-institutes:grid.10698.36
310 schema:familyName Bateman
311 schema:givenName Lori A.
312 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354170443.83
313 rdf:type schema:Person
314 sg:person.016672356017.04 schema:affiliation grid-institutes:grid.26009.3d
315 schema:familyName Samsa
316 schema:givenName Gregory P.
317 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016672356017.04
318 rdf:type schema:Person
319 sg:person.0641063674.88 schema:affiliation grid-institutes:grid.26009.3d
320 schema:familyName Setji
321 schema:givenName Tracy L.
322 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0641063674.88
323 rdf:type schema:Person
324 sg:person.0724731546.00 schema:affiliation grid-institutes:grid.26009.3d
325 schema:familyName Piner
326 schema:givenName Lucy W.
327 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0724731546.00
328 rdf:type schema:Person
329 sg:person.0727212312.25 schema:affiliation grid-institutes:grid.26009.3d
330 schema:familyName Willis
331 schema:givenName Leslie H.
332 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0727212312.25
333 rdf:type schema:Person
334 sg:person.0755300141.18 schema:affiliation grid-institutes:grid.26009.3d
335 schema:familyName Granville
336 schema:givenName Esther O.
337 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755300141.18
338 rdf:type schema:Person
339 sg:pub.10.1007/s001250051249 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027638373
340 https://doi.org/10.1007/s001250051249
341 rdf:type schema:CreativeWork
342 grid-institutes:grid.10698.36 schema:alternateName University of North Carolina at Chapel Hill, Center for Health Promotion and Disease Prevention, Chapel Hill, NC, USA
343 schema:name Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA
344 University of North Carolina at Chapel Hill, Center for Health Promotion and Disease Prevention, Chapel Hill, NC, USA
345 rdf:type schema:Organization
346 grid-institutes:grid.26009.3d schema:alternateName Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA
347 Division of Cardiology, Duke University School of Medicine, Durham,, NC, USA
348 Division of Endocrinology, Duke University School of Medicine, Durham, NC, USA
349 Division of Geriatrics, Duke University School of Medicine, Durham, NC, USA
350 Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA
351 schema:name Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA
352 Division of Cardiology, Duke University School of Medicine, Durham,, NC, USA
353 Division of Endocrinology, Duke University School of Medicine, Durham, NC, USA
354 Division of Geriatrics, Duke University School of Medicine, Durham, NC, USA
355 Duke Molecular Physiology Institute, Department of Medicine, Duke University School of Medicine, 300 North Duke Street, 27701, Durham, NC, USA
356 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...